/ Blog / Douglas Insights Adds Acute Respiratory Distress Syndrome (ARDS) Market Research Report To Its Comparison Engine


03 October 2022

Douglas Insights Adds Acute Respiratory Distress Syndrome (ARDS) Market Research Report To Its Comparison Engine

The Douglas Insights Engine is the world’s first market comparison engine. People from all industries, including market analytics, research, business, and even industry professionals, can make use of the engine to identify the growth opportunities, market drivers, trends, and even hindrances to the market. With the addition of ARDS to the market, the industry professional can predict future market trends and sort out all the relevant information with the help of a table of contents, date of publishing, price, and rating. 



Acute Respiratory Distress Syndrome (ARDS) is a medical condition in which the lungs are unable to take in enough oxygen to be able to supply to the other organs, which greatly impacts their ability to function normally. ARDS is usually a result of other underlying medical conditions, including sepsis, pneumonia, and injuries in the head, chest, and other vital areas. Common symptoms of ARDS include low blood pressure, shortness of breath, confusion, fatigue, and rapid breathing. Treatment for ARDS usually relies on ventilation, fluids through IV, surfactants, and other medicine that is administered through the respiratory route. 


The market for ARDS treatment is growing and is set to grow for the next couple of years. The main drivers in market growth include newer products in the pipelines, more awareness regarding disease management, and an increase in intensive care units for neonates, in whom the incidence of the disease is greater than in adults. The increase in research in stem cell treatments and further research and development projects will also fuel the market’s growth in the coming years. Because of these driving forces, the market will continue to grow for the next couple of years.


However, there are a few restricting factors in the market’s expansion. These include the limited number of medicines that have so far been approved for the treatment of the disease. Even the ventilation devices that can be used for effective treatment of the disease are few and far in between, which is why the market’s growth will be somewhat restricted for the next couple of years. 


The most significant shares in the market are currently taken up by North America. This is because North America is the most research-oriented region in the healthcare and medical industry, and they are coming up with newer, more innovative modes of treatment consistently. Other than that, Europe, followed by the Asia Pacific, also hold significant shares in the market. The key players in the ARDS treatment industry include Faron Pharmaceuticals, mondoBIOTECH AG, Athersys, GlaxoSmithKline, Pfizer Inc, Teva Pharmaceuticals, and Altor BioSciences, among many others. These players have the financial backing along with the necessary information and tools to eliminate the restraining factors and further the driving forces of the market in the near future as well. 


The drugs used for the treatment of ARDS include bronchodilators, vasoconstrictors, surfactants, steroids, antibiotics, nitric oxide, and sedatives, among many others. These drugs can be inhaled, transmitted through the IV route, or taken orally by the patient, depending on their needs and their functionality. By the end of 202, we will likely be able to see monumental growth in the ARDS in North America because of their ongoing research and development projects. We will also be able to see market growth in Latin America, the Middle East, and even regions in Africa because the market growth at present is minimal, and the needs are increasing. 

Share on

Continue Reading

Five Biggest Scented-Candle Manufacturers Worldwide

Scented candles are soothing, rejuvenating, and relaxing creations commonly used for their pleasant and aromatic after-scent.

Forbes Names Mr. Beast World's Richest Creator

Jimmy Donaldson has been named the richest creator in the world. Now you must be wondering who that is. He is the same person we all lovingly know as Mr. Beast.

Kanye West's Yeezy Brand Is Ending Its Contract With Gap

Click here to learn about the end of the Yeezy Gap deal and how Kanye West's vision for Yeezy is driving his brand out of corporate ties.

Five Leading Manufacturers Of Commercial Vehicles

Technological advancements and automation encourage commercial vehicle manufacturers to produce safer, better, and more robust trucks to encourage comfortable and reliable drives. Although the commercial vehicle market was severely impacted due to the pandemic and limited trading and supply chains, some producers remained at the top of their production and innovation. Therefore, their market shares remained more or less constant as well.

Recent Press Releases

Douglas Insights Adds Deep Learning Market Research Reports to Its Comparison Engine

Douglas Insights has assessed all elements of the deep learning market and uncovered the changes in market trends due to the rising demand for data mining an...

Douglas Insights Adds Custom T-Shirt Printing Market Research Reports to Its Comparison...

Douglas Insights wanted to expand its comparison engine with market reports that identify all the players in a market space. They also contain notes from res...

Douglas Insights Adds Political Campaign Software Market Research Reports to Its Compar...

Douglas Insights is excited to announce the addition of a new feature to its comparison engine: political campaign software market research reports. The new ...

Douglas Insights Adds Fuel Cells Market Research Reports to Its Comparison Engine

Douglas Insights has analysed various aspects of the Fuel Cells Market and revealed the changes in market trends due to increased awareness of climate change...